Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
about
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infectionsMucormycosis in a renal transplant recipient: case report and comprehensive review of literatureDiagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questionsIsavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsIsavuconazole: A New Broad-Spectrum Triazole Antifungal AgentPharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelThe challenge of managing fusariosisComparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrumIn Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales OrderIn vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model.Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections.Profile of isavuconazole and its potential in the treatment of severe invasive fungal infectionsFungal infections of the skin and nail: new treatment options.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Isavuconazonium: first global approval.The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.Systemic Antifungal Agents: Current Status and Projected Future Developments.New facets of antifungal therapy.Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections.Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.Isavuconazole: a new extended spectrum triazole for invasive mold diseases.Diagnosis, classification, and therapeutic interventions for sinopulmonary Aspergillosis.The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).Drugs in Clinical Development for Fungal Infections.In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method.Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.Newer antifungal agents.Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations.New Horizons in Antifungal Therapy.
P2860
Q26744049-FCE35C9E-7B5C-45C4-B193-F1B981B4B339Q26860727-9083BBE2-7DB8-468D-BB1C-A7C42D02CA21Q27015890-1C801735-2F31-41DC-935F-8536AC451E59Q28067726-654A585E-CB7D-4736-8518-D4CC5D8F2D1FQ28082019-754E10CA-C55E-44DC-8E8B-731B83F0543EQ35385554-2651CF7A-4FAE-4CB0-9FB3-A6CA032987BBQ35693680-4D98BC9F-0FE4-4367-98C8-31E0A6389227Q35746245-198BD79B-57D1-4AD8-A6D2-90A58CF404C6Q36290764-3D57915E-644C-41B4-A6D5-9E933BD4AD9CQ37036173-02A7F028-7E4C-422D-89B7-689D86D2EBFCQ37096795-78E6C590-B0E7-49AA-8E66-434CCF853694Q37119937-5E1598E1-22A2-422A-BE70-D6A126B7A469Q37125086-5287AFFC-B566-4309-8792-45536721EFA1Q37263435-F757FCD0-8A1B-468C-847A-3AEA541700D5Q37562454-D1C00E70-704F-43E1-B7C3-222CD80FBD71Q38005226-BFB89065-82A3-4074-92FC-70CE1CC6009BQ38159688-DFF11132-F18D-4453-8E82-544B2C0005FFQ38252946-DC5AECD5-6DE8-4788-896C-11BBAA150D41Q38285488-130344FF-A96C-40A4-9674-0C0F80416A37Q38436002-A817814D-1C96-4843-9867-426C2E6E0F27Q38534865-69CC2E76-ECA3-40A5-966D-10E3A32DD3B5Q38644817-5A7985E3-1F5F-41BF-A937-4F86D1E4AC7BQ38796140-D7289A91-95C2-4B70-9FC6-A7F43931F090Q38797864-93300B66-B4A5-4BB0-A508-D42E4245A4B2Q38829932-80CCA8BA-E379-499E-A66B-BA70F708B88BQ38939506-4326647A-0CF4-4F34-889F-9EE810F5AF52Q38987096-C672338B-E93D-44C0-BDE7-1A1FA929791DQ39003715-EC5CC6D8-FEC7-4AFA-8F3E-3415039C3282Q39091924-E4C308C9-ECB2-45F8-9AC0-4945736D7C03Q39189670-3C13E241-5960-421D-B94C-5BC6F6851F8CQ40070714-CF1FA863-8AB0-4F76-A0E9-87097E5240A3Q41569666-5CE54D7A-EF09-4109-8EAA-3BD3978D37A7Q41702288-96DC7A49-1D73-4F57-A809-635CFABFE2E9Q41771784-6B94AFBB-3279-4052-A1F9-D9BE54F3FB88Q42234620-979F6AEF-FCB7-4081-A9CA-7EE3B46FD7D7Q44855715-5E3E740C-23ED-4277-9E65-E6A0A5FD0067Q46876288-D70C6D6B-4BA4-4A8B-AD73-6B292C93250EQ47697132-FCF9B35C-C667-439D-A766-488683C20892Q47697145-46374982-1D10-4C50-AE0D-409D49AD71B6Q48149179-B0B7B001-7260-406A-AF74-122CEC1913C3
P2860
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
@en
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
@nl
type
label
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
@en
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
@nl
prefLabel
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
@en
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
@nl
P1433
P1476
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole
@en
P2093
George R Thompson
P2888
P304
P356
10.1007/S11046-010-9324-3
P577
2010-06-05T00:00:00Z